Of importance is that our previous report suggested that, even in pMMR/MSS CRC, a small subset of the patients (approximately 10% of all pMMR/MSS cases) displayed high infiltration of CD8+ T cells and activation of IFN response [25], which could contribute to a favorable response to ICI treatment [15]. The gene discussed is CD8A; the disease is colorectal carcinoma.